IDF creating new Type 2 diabetes guidelines with global experts, focusing on patient-centered care and global accessibility.

A newly designed therapy following an islet cell transplant could mean people with type 1 diabetes no longer need to inject ...

Weight-loss drugs, particularly newer options like GLP-1 receptor agonists, are revolutionising the treatment of obesity and ...

The FDA is warning that patients taking GLP-1s may be at a higher risk of inhaling fluid into their lungs while under ...

The weight-loss drug Ozempic can help reduce stroke patients' risk of a heart attack or death, a new study says.

The FDA warns GLP-1 weight loss drug users of aspiration risks during anaesthesia Learn what this update means and how to ...

SGLT2 inhibitors and GLP-1 receptor agonists exhibit renoprotective effects in patients with CKD with and without diabetes.

In an analysis of more than 7,000 stroke survivors, those who were taking either a GLP1-receptor agonist or an SGLT2 ...

Tirzepatide, known under the brand name Mounjaro is prescribed for type 2 diabetes, but has been shown in clinical trials to ...

and sometimes people are told to change their diabetes treatment. If you or your family member start a new diabetes treatment, make sure to ask the right questions from the doctor. Let us tell you ...

Yet exercise can sometimes be deceptive. Years before starting Virta Health, while cofounding the real-estate company Trulia, ...